Development of a Metastatic Uveal Melanoma Prognostic risk Score (MUMPS) for use in patients receiving immune checkpoint inhibitors

Deirdre Kelly; April A. N. Rose; Thiago Pimentel Muniz; David Hogg; Marcus O. Butler; Samuel D. Saibil; Ian King; Zaid Saeed Kamil; Danny Ghazarian; Kendra Ross; Marco Iafolla; Daniel V. Araujo; John Waldron; Normand Laperriere; Hatem Krema; Anna Spreafico

doi:10.1101/2021.02.28.21252611

Development of a Metastatic Uveal Melanoma Prognostic risk Score (MUMPS) for use in patients receiving immune checkpoint inhibitors

Deirdre Kelly, April A. N. Rose, Thiago Pimentel Muniz, David Hogg, Marcus O. Butler, Samuel D. Saibil, Ian King, Zaid Saeed Kamil, Danny Ghazarian, Kendra Ross, Marco Iafolla, Daniel V. Araujo, John Waldron, Normand Laperriere, Hatem Krema, Anna Spreafico

doi: https://doi.org/10.1101/2021.02.28.21252611

Deirdre Kelly

1Division of Medical Oncology and Hematology, Princess Margaret Cancer Center, University Health Network, Toronto, ON, Canada

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

April A. N. Rose

2Department of Oncology, McGill University, Montreal QC, Canada

3Segal Cancer Centre, Jewish General Hospital, Montreal, QC, Canada

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
For correspondence: anna.spreafico{at}uhn.ca april.rose{at}uhn.ca

Thiago Pimentel Muniz

1Division of Medical Oncology and Hematology, Princess Margaret Cancer Center, University Health Network, Toronto, ON, Canada

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

David Hogg

1Division of Medical Oncology and Hematology, Princess Margaret Cancer Center, University Health Network, Toronto, ON, Canada

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Marcus O. Butler

1Division of Medical Oncology and Hematology, Princess Margaret Cancer Center, University Health Network, Toronto, ON, Canada

4Tumor Immunotherapy Program, Princess Margaret Cancer Center, Toronto, ON, Canada

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Samuel D. Saibil

1Division of Medical Oncology and Hematology, Princess Margaret Cancer Center, University Health Network, Toronto, ON, Canada

4Tumor Immunotherapy Program, Princess Margaret Cancer Center, Toronto, ON, Canada

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Ian King

5Department of Laboratory Medicine and Pathobiology, University of Toronto

6Princess Margaret Cancer Center, University Health Network

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Zaid Saeed Kamil

5Department of Laboratory Medicine and Pathobiology, University of Toronto

6Princess Margaret Cancer Center, University Health Network

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Danny Ghazarian

5Department of Laboratory Medicine and Pathobiology, University of Toronto

6Princess Margaret Cancer Center, University Health Network

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Kendra Ross

4Tumor Immunotherapy Program, Princess Margaret Cancer Center, Toronto, ON, Canada

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Marco Iafolla

1Division of Medical Oncology and Hematology, Princess Margaret Cancer Center, University Health Network, Toronto, ON, Canada

4Tumor Immunotherapy Program, Princess Margaret Cancer Center, Toronto, ON, Canada

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Daniel V. Araujo

1Division of Medical Oncology and Hematology, Princess Margaret Cancer Center, University Health Network, Toronto, ON, Canada

7Department of Medical Oncology, Hospital de Base, Sao Jose do Rio Preto, SP, Brazil

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

John Waldron

8Department of Radiation Oncology, Princess Margaret Cancer Centre, University of Toronto

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Normand Laperriere

8Department of Radiation Oncology, Princess Margaret Cancer Centre, University of Toronto

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Hatem Krema

9Ocular Oncology Service Krembil Research Institute, Princess Margaret Cancer Centre/University Health Network

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Anna Spreafico

1Division of Medical Oncology and Hematology, Princess Margaret Cancer Center, University Health Network, Toronto, ON, Canada

4Tumor Immunotherapy Program, Princess Margaret Cancer Center, Toronto, ON, Canada

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
For correspondence: anna.spreafico{at}uhn.ca april.rose{at}uhn.ca

Abstract
Full Text
Info/History
Metrics
Supplementary material
Data/Code
Preview PDF

Data Availability

Availability of data and material: De-identified patient data are available upon reasonable request.

View the discussion thread.

PreviousNext

Posted March 02, 2021.

Download PDF

Supplementary Material

Data/Code

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Development of a Metastatic Uveal Melanoma Prognostic risk Score (MUMPS) for use in patients receiving immune checkpoint inhibitors

Message Subject (Your Name) has forwarded a page to you from medRxiv

Message Body (Your Name) thought you would like to see this page from the medRxiv website.

Your Personal Message

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Development of a Metastatic Uveal Melanoma Prognostic risk Score (MUMPS) for use in patients receiving immune checkpoint inhibitors

medRxiv 2021.02.28.21252611; doi: https://doi.org/10.1101/2021.02.28.21252611

Share This Article:

Citation Tools

Development of a Metastatic Uveal Melanoma Prognostic risk Score (MUMPS) for use in patients receiving immune checkpoint inhibitors

medRxiv 2021.02.28.21252611; doi: https://doi.org/10.1101/2021.02.28.21252611

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

Tweet Widget
Facebook Like
Google Plus One

Subject Area

Oncology

Subject Areas

All Articles

Addiction Medicine (349)
Allergy and Immunology (668)
Allergy and Immunology (668)
Anesthesia (181)
Cardiovascular Medicine (2648)
Dentistry and Oral Medicine (316)
Dermatology (223)
Emergency Medicine (399)
Endocrinology (including Diabetes Mellitus and Metabolic Disease) (942)
Epidemiology (12228)
Forensic Medicine (10)
Gastroenterology (759)
Genetic and Genomic Medicine (4103)
Geriatric Medicine (387)
Health Economics (680)
Health Informatics (2657)
Health Policy (1005)
Health Systems and Quality Improvement (985)
Hematology (363)
HIV/AIDS (851)
Infectious Diseases (except HIV/AIDS) (13695)
Intensive Care and Critical Care Medicine (797)
Medical Education (399)
Medical Ethics (109)
Nephrology (436)
Neurology (3882)
Nursing (209)
Nutrition (577)
Obstetrics and Gynecology (739)
Occupational and Environmental Health (695)
Oncology (2030)
Ophthalmology (585)
Orthopedics (240)
Otolaryngology (306)
Pain Medicine (250)
Palliative Medicine (75)
Pathology (473)
Pediatrics (1115)
Pharmacology and Therapeutics (466)
Primary Care Research (452)
Psychiatry and Clinical Psychology (3432)
Public and Global Health (6527)
Radiology and Imaging (1403)
Rehabilitation Medicine and Physical Therapy (814)
Respiratory Medicine (871)
Rheumatology (409)
Sexual and Reproductive Health (410)
Sports Medicine (342)
Surgery (448)
Toxicology (53)
Transplantation (185)
Urology (165)